-
公开(公告)号:US20230002480A1
公开(公告)日:2023-01-05
申请号:US17677757
申请日:2022-02-22
申请人: Dongkyoon Kim , Guy Cavet , University of Maryland, Baltimore , The United States Government as Represented by the Department of Veterans Affairs
发明人: Mohammad Sajadi , George K. Lewis , Anthony DeVico , Dongkyoon Kim , Guy Cavet
摘要: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof.
-
公开(公告)号:US20240117018A1
公开(公告)日:2024-04-11
申请号:US18314490
申请日:2023-05-09
申请人: University of Maryland, Baltimore , The United States Government as Represented by the Department of Veterans Affairs
发明人: Mohammad Sajadi , George K. Lewis , Anthony DeVico
CPC分类号: C07K16/1063 , A61K39/42 , A61K45/06 , A61P31/18 , C07K16/1045 , C07K2317/34 , C07K2317/565 , C07K2317/732 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof.
-
公开(公告)号:US20200172601A1
公开(公告)日:2020-06-04
申请号:US16626163
申请日:2018-06-22
申请人: Dongkyoon Kim , Guy Cavet , University of Maryland, Baltimore , The United States Government as Represented by the Department of Veterans Affairs
发明人: Mohammad Sajadi , George K. Lewis , Anthony DeVico , Amir Dashti , Marzena E. Pazgier , William David Tolbert , Dongkyoon Kim , Guy Cavet
摘要: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof. Specifically, the invention provides isolated anti-HIV antibodies that are capable of neutralizing at least 95% of the HIV pseudoviruses listed in Table 1 and neutralizing 100% of the HIV clade B, G and D viruses listed in Table 1 with an IC50 value of less than 50 ug/mL. Further provides are the sequences especially complementarity-determining region (CDR) sequences of antibodies disclosed.
-
公开(公告)号:US11760789B2
公开(公告)日:2023-09-19
申请号:US16725596
申请日:2019-12-23
申请人: University of Maryland, Baltimore , The United States Government as Represented by the Department of Veterans Affairs
发明人: Mohammad Sajadi , George K. Lewis , Anthony DeVico
CPC分类号: C07K16/1063 , A61K39/42 , A61K45/06 , A61P31/18 , C07K16/1045 , C07K2317/34 , C07K2317/565 , C07K2317/732 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof.
-
公开(公告)号:US20200239551A1
公开(公告)日:2020-07-30
申请号:US16725596
申请日:2019-12-23
申请人: University of Maryland, Baltimore , The United States Government as Represented by the Department of Veterans Affairs
发明人: Mohammad Sajadi , George K. Lewis , Anthony DeVico
摘要: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof.
-
公开(公告)号:US11067583B2
公开(公告)日:2021-07-20
申请号:US16302525
申请日:2017-05-25
申请人: University of Maryland, Baltimore , The United States of America as represented by the Department of Veterans Affairs
发明人: Mohammad Sajadi , Anthony DeVico , George Lewis
IPC分类号: C07K16/00 , C07H21/04 , C12P21/08 , A61K39/395 , C07K1/00 , G01N33/68 , C07K1/22 , C07K16/10 , H01J49/26
摘要: The present invention provides a method of making an antibody by identifying a circulating antibody with activity from a subject comprising i) subjecting biological fluid selected from the group consisting of blood, plasma and serum and combinations thereof from the subject to one or more rounds of affinity chromatography to purify the circulating antibody; ii) optionally further subjecting the circulating antibody to isoelectric focusing to purify the circulating antibody based on charge; iii) testing the purified circulating antibody for activity; iv) digesting the purified circulating antibody from parts i) or ii) to create an antibody fragment; v) subjecting the antibody fragment to mass spectrometry to generate a mass assignment and a deduced amino acid sequence of the antibody fragment; vi) comparing the deduced amino acid sequence with an amino acid sequence of an antibody generated from the subject's B-cells to identify an antibody sequence that matches the deduced amino acid sequence; vii) generating an antibody comprising light chain and heavy chain CDR sequences of the B-cell antibody that matches the deducted amino acid sequence of party vi); and viii) testing the antibody of part vii) for activity.
-
公开(公告)号:US20200182883A1
公开(公告)日:2020-06-11
申请号:US16302525
申请日:2017-05-25
申请人: University of Maryland, Baltimore , The United States of America as represented by the Department of Veterans Affairs
发明人: Mohammad Sajadi , Anthony DeVico , George Lewis
摘要: The present invention provides a method of making an antibody by identifying a circulating antibody with activity from a subject comprising i) subjecting biological fluid selected from the group consisting of blood, plasma and serum and combinations thereof from the subject to one or more rounds of affinity chromatography to purify the circulating antibody; ii) optionally further subjecting the circulating antibody to isoelectric focusing to purify the circulating antibody based on charge; iii) testing the purified circulating antibody for activity; iv) digesting the purified circulating antibody from parts i) or ii) to create an antibody fragment; v) subjecting the antibody fragment to mass spectrometry to generate a mass assignment and a deduced amino acid sequence of the antibody fragment; vi) comparing the deduced amino acid sequence with an amino acid sequence of an antibody generated from the subject's B-cells to identify an antibody sequence that matches the deduced amino acid sequence; vii) generating an antibody comprising light chain and heavy chain CDR sequences of the B-cell antibody that matches the deducted amino acid sequence of party vi); and viii) testing the antibody of part vii) for activity.
-
-
-
-
-
-